Research output

Nilvadipine in mild to moderate Alzheimer disease: A randomised controlled trial

Research output: Contribution to journalArticleAcademicpeer-review

Associated researcher

  • NILVAD Study Grp
  • Lawlor, B.
  • Segurado, R.
  • Kennelly, S.
  • Rikkert, M. G. M. O.
  • Howard, R.
  • Pasquier, F.
  • Borjesson-Hanson, A.
  • Tsolaki, M.
  • Lucca, U.
  • Molloyid, D. W.
  • Coen, R.
  • Riepe, M. W.
  • Kalman, J.
  • Kenny, R. A.
  • Cregg, F.
  • O'Dwyer, S.
  • Walsh, C.
  • Adams, J.
  • Banzi, R.
  • Breuilh, L.
  • Daly, L.
  • Hendrix, S.
  • Aisen, P.
  • Gaynor, S.
  • Sheikhi, A.
  • Taekema, D. G.
  • Verhey, F.R.J.

  • Nemni, R.
  • Nobili, F.
  • Franceschi, M.
  • Frisoni, G.
  • Zanetti, O.
  • Konsta, A.
  • Anastasios, O.
  • Nenopoulou, S.
  • Tsolaki-Tagaraki, F.
  • Pakaski, M.
  • Dereeper, O.
  • de la Sayette, V.
  • Senechal, O.
  • Lavenu, I.
  • Devendeville, A.
  • Calais, G.
  • Crawford, F.
  • Mullan, M.

Associated organisations

    Research areas

  • COGNITIVE DECLINE, DEMENTIA, PREVENTION, NEUROPATHOLOGY, HYPERTENSION, BLOCKERS
View graph of relations

Details

Original languageEnglish
Article numbere1002660
Number of pages20
JournalPLoS Medicine
Volume15
Issue number9
DOIs
Publication statusPublished - 1 Sep 2018